SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-001644
Filing Date
2022-01-05
Accepted
2022-01-05 19:44:12
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm221949-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm221949-6_4seq1.xml 4 4017
  Complete submission text file 0001104659-22-001644.txt   5438
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 7TH AVENUE NE ST. PETERSBURG FL 33701
Business Address
White Mark K. (Reporting) CIK: 0001786183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 22513192